Quarterly report · Q2
4272.TEDINET S100S30O
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥97.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥198.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥13.6bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥8.3bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.8bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥16.4bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥11.3bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥349.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥322.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥329.5bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥81.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥67.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥267.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥255.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥259.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥48.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥57.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥52.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.74 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.69 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.72 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.33 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥67.02 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 76.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥78m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥3.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥28.0bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥27.9bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥77m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥39.5bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥98.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥97.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥78m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥8.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥82m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥3.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.7bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.6bn |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| jpcrp040300-q2r_E00836-000Fine Chemicals Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥30.0bn |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00836-000Life Science Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.2bn |
| jpcrp040300-q2r_E00836-000Mobility And Imaging Business Unitreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥102.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥102.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥82m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 573
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from redemption of securities inv cf | CurrentYTDDuration | 371000000 | JPY |
| Proceeds from redemption of investment securities inv cf | Prior1YTDDuration | 237000000 | JPY |
| Proceeds from redemption of investment securities inv cf | CurrentYTDDuration | 122000000 | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | Prior1YTDDuration | － | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | CurrentYTDDuration | -366000000 | JPY |
| Payments of long term loans receivable inv cf | Prior1YTDDuration | － | JPY |
| Payments of long term loans receivable inv cf | CurrentYTDDuration | -3000000 | JPY |
| Purchase of long term prepaid expenses inv cf | Prior1YTDDuration | -221000000 | JPY |
| Purchase of long term prepaid expenses inv cf | CurrentYTDDuration | -318000000 | JPY |
| Removal loss of property plant and equipment inv cf | Prior1YTDDuration | -277000000 | JPY |
| Removal loss of property plant and equipment inv cf | CurrentYTDDuration | -262000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 4000000 | JPY |
| Other net inv cf | CurrentYTDDuration | 87000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -9238000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -12157000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -681000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 257000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 8000000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -1167000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -1618000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -0 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -4198000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -4130000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -42000000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -19000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -108000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -146000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -6198000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 2340000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 3053000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 3370000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -348000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 4076000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 52962000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 53096000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 52613000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 57172000000 | JPY |
| Payrolls selling expenses | Prior1YTDDuration | 2937000000 | JPY |
| Payrolls selling expenses | CurrentYTDDuration | 2929000000 | JPY |
| Bonuses and allowance sga | Prior1YTDDuration | 998000000 | JPY |
| Bonuses and allowance sga | CurrentYTDDuration | 885000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 88000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 143000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 320000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 310000000 | JPY |
| Payrolls general and administrative expenses | Prior1YTDDuration | 2011000000 | JPY |
| Payrolls general and administrative expenses | CurrentYTDDuration | 2224000000 | JPY |
| Bonuses and allowance general and administrative expenses | Prior1YTDDuration | 432000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |